DexCom, Inc.

NASDAQ:DXCM

70.69 (USD) • At close March 14, 2025
Bedrijfsnaam DexCom, Inc.
Symbool DXCM
Munteenheid USD
Prijs 70.69
Beurswaarde 27,623,672,680
Dividendpercentage 0%
52-weken bereik 62.34 - 142
Industrie Medical Devices
Sector Healthcare
CEO Mr. Kevin Ronald Sayer
Website https://www.dexcom.com

An error occurred while fetching data.

Over DexCom, Inc.

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an

Vergelijkbare Aandelen

Biogen Inc. logo

Biogen Inc.

BIIB

139.44 USD

IDEXX Laboratories, Inc. logo

IDEXX Laboratories, Inc.

IDXX

415.3 USD

Royalty Pharma plc logo

Royalty Pharma plc

RPRX

32.77 USD

Seagen Inc. logo

Seagen Inc.

SGEN

228.74 USD

Walgreens Boots Alliance, Inc. logo

Walgreens Boots Alliance, Inc.

WBA

11.23 USD

Align Technology, Inc. logo

Align Technology, Inc.

ALGN

166.2 USD

Illumina, Inc. logo

Illumina, Inc.

ILMN

85.6 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)